Platelet-derived growth factor signaling in human malignancies

Kun Wei Liu, Bo Hu*, Shi Yuan Cheng

*Corresponding author for this work

Research output: Contribution to journalEditorial

7 Citations (Scopus)

Abstract

Platelet-derived growth factors (PDGFs) and their receptors were identified and purified decades ago. PDGFs are important during normal development and in human cancers. In particular, autocrine PDGF signaling has been implicated in various types of malignancies such as gliomas and leukemia. In contrast, paracrine signaling was found in cancers that originate from epithelial cells, where it may be involved in stromal cell recruitment, metastasis, and epithelial-m esenchymal transition. This editorial briefly discusses autocrine and paracrine PDGF signaling and their roles in human cancers, and introduces a series of review articles in this issue that address the possible roles of PDGFs in various processes involved in different types of cancers.

Original languageEnglish (US)
Pages (from-to)581-584
Number of pages4
JournalChinese Journal of Cancer
Volume30
Issue number9
DOIs
StatePublished - Sep 27 2011

Fingerprint

Platelet-Derived Growth Factor
Neoplasms
Paracrine Communication
Platelet-Derived Growth Factor Receptors
Human Development
Stromal Cells
Glioma
Leukemia
Epithelial Cells
Neoplasm Metastasis

Keywords

  • Cancer
  • Drug resistance
  • Platelet-derived growth factor
  • Tumor progression

ASJC Scopus subject areas

  • Oncology

Cite this

@article{c28b3737a2504b3e8b36b6cf9b02680a,
title = "Platelet-derived growth factor signaling in human malignancies",
abstract = "Platelet-derived growth factors (PDGFs) and their receptors were identified and purified decades ago. PDGFs are important during normal development and in human cancers. In particular, autocrine PDGF signaling has been implicated in various types of malignancies such as gliomas and leukemia. In contrast, paracrine signaling was found in cancers that originate from epithelial cells, where it may be involved in stromal cell recruitment, metastasis, and epithelial-m esenchymal transition. This editorial briefly discusses autocrine and paracrine PDGF signaling and their roles in human cancers, and introduces a series of review articles in this issue that address the possible roles of PDGFs in various processes involved in different types of cancers.",
keywords = "Cancer, Drug resistance, Platelet-derived growth factor, Tumor progression",
author = "Liu, {Kun Wei} and Bo Hu and Cheng, {Shi Yuan}",
year = "2011",
month = "9",
day = "27",
doi = "10.5732/cjc.011.10300",
language = "English (US)",
volume = "30",
pages = "581--584",
journal = "Cancer Communications",
issn = "1000-467X",
publisher = "BioMed Central Ltd.",
number = "9",

}

Platelet-derived growth factor signaling in human malignancies. / Liu, Kun Wei; Hu, Bo; Cheng, Shi Yuan.

In: Chinese Journal of Cancer, Vol. 30, No. 9, 27.09.2011, p. 581-584.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Platelet-derived growth factor signaling in human malignancies

AU - Liu, Kun Wei

AU - Hu, Bo

AU - Cheng, Shi Yuan

PY - 2011/9/27

Y1 - 2011/9/27

N2 - Platelet-derived growth factors (PDGFs) and their receptors were identified and purified decades ago. PDGFs are important during normal development and in human cancers. In particular, autocrine PDGF signaling has been implicated in various types of malignancies such as gliomas and leukemia. In contrast, paracrine signaling was found in cancers that originate from epithelial cells, where it may be involved in stromal cell recruitment, metastasis, and epithelial-m esenchymal transition. This editorial briefly discusses autocrine and paracrine PDGF signaling and their roles in human cancers, and introduces a series of review articles in this issue that address the possible roles of PDGFs in various processes involved in different types of cancers.

AB - Platelet-derived growth factors (PDGFs) and their receptors were identified and purified decades ago. PDGFs are important during normal development and in human cancers. In particular, autocrine PDGF signaling has been implicated in various types of malignancies such as gliomas and leukemia. In contrast, paracrine signaling was found in cancers that originate from epithelial cells, where it may be involved in stromal cell recruitment, metastasis, and epithelial-m esenchymal transition. This editorial briefly discusses autocrine and paracrine PDGF signaling and their roles in human cancers, and introduces a series of review articles in this issue that address the possible roles of PDGFs in various processes involved in different types of cancers.

KW - Cancer

KW - Drug resistance

KW - Platelet-derived growth factor

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=80053077850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053077850&partnerID=8YFLogxK

U2 - 10.5732/cjc.011.10300

DO - 10.5732/cjc.011.10300

M3 - Editorial

C2 - 21880178

AN - SCOPUS:80053077850

VL - 30

SP - 581

EP - 584

JO - Cancer Communications

JF - Cancer Communications

SN - 1000-467X

IS - 9

ER -